BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 2937798)

  • 1. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans.
    Kimura T; Abe K; Ota K; Omata K; Shoji M; Kudo K; Matsui K; Inoue M; Yasujima M; Yoshinaga K
    J Clin Endocrinol Metab; 1986 May; 62(5):1003-10. PubMed ID: 2937798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an oral water load and intravenous administration of isotonic glucose, hypertonic saline, mannitol and furosemide on the release of atrial natriuretic peptide in men.
    Yamasaki Y; Nishiuchi T; Kojima A; Saito H; Saito S
    Acta Endocrinol (Copenh); 1988 Oct; 119(2):269-76. PubMed ID: 2972152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearances of arginine vasopressin in normal subjects.
    Moses AM; Jones C; Yucha CB
    J Clin Endocrinol Metab; 1990 Jan; 70(1):222-9. PubMed ID: 2136743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal atrial natriuretic factor and arginine vasopressin responses to hyperosmolality and hypervolemia.
    Ross MG; Ervin MG; Lam RW; Leake RD; Fisher DA
    Pediatr Res; 1988 Sep; 24(3):318-21. PubMed ID: 2974940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypertonic saline infusion and water drinking on atrial peptide.
    Salazar FJ; Granger JP; Joyce ML; Burnett JC; Bove AA; Romero JC
    Am J Physiol; 1986 Dec; 251(6 Pt 2):R1091-4. PubMed ID: 2947480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of vagal nerves and atrial natriuretic hormone in vasopressin release and a diuresis under hypertonic volume expansion.
    Sato K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Yamamoto T; Funyu T; Yoshinaga K; Abe K
    Acta Endocrinol (Copenh); 1993 Jul; 129(1):65-74. PubMed ID: 7688922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man.
    Rittmaster RS; Cutler GB; Gold PW; Brandon DD; Tomai T; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1987 Feb; 64(2):371-6. PubMed ID: 3025246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in plasma concentrations of atrial natriuretic peptide during infusion of hypertonic saline in conscious newborn calves.
    Amadieu-Farmakis M; Giry J; Barlet JP
    J Endocrinol; 1988 Oct; 119(1):23-9. PubMed ID: 2973511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humans.
    Burrell LM; Lambert HJ; Baylis PH
    Am J Physiol; 1991 Mar; 260(3 Pt 2):R475-9. PubMed ID: 1825748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of the renin-aldosterone system and antidiuretic hormone to oral water loading and hypertonic saline infusion during and after pregnancy.
    Vaklotton MB; Davison JM; Riondel AM; Lindheimer MD
    Clin Exp Hypertens B; 1982; 1(2-3):385-400. PubMed ID: 6754157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide inhibits osmolality-induced arginine vasopressin release in man.
    Allen MJ; Ang VT; Bennett ED; Jenkins JS
    Clin Sci (Lond); 1988 Jul; 75(1):35-9. PubMed ID: 2970360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of plasma volume and osmolality on secretion of atrial natriuretic peptide and vasopressin in man.
    Kamoi K; Sato F; Arai O; Ishibashi M; Yamaji T
    Acta Endocrinol (Copenh); 1988 May; 118(1):51-8. PubMed ID: 2968747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human atrial natriuretic peptide on renal function and vasopressin release.
    Kimura T; Abe K; Shoji M; Tsunoda K; Matsui K; Ota K; Inoue M; Yasujima M; Yoshinaga K
    Am J Physiol; 1986 May; 250(5 Pt 2):R789-94. PubMed ID: 2939732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of urinary AQP2 and unaffected response to hypertonic saline after 24 hours of fasting in humans.
    Starklint J; Bech JN; Pedersen EB
    Kidney Int; 2005 Mar; 67(3):1010-8. PubMed ID: 15698439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of furosemide and acute salt loading on vasopressin and renin secretion in the fetal lamb.
    Siegel SR; Leake RD; Weitzman RE; Fisher DA
    Pediatr Res; 1980 Jul; 14(7):869-71. PubMed ID: 6997818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atrial natriuretic hormone on vasopressin and thirst response to osmotic stimulation in human subjects.
    Wazna-Wesly JM; Meranda DL; Carey P; Shenker Y
    J Lab Clin Med; 1995 Jun; 125(6):734-42. PubMed ID: 7769367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of V1- and V2-vasopressin (AVP) antagonists on the pressor, AVP and atrial natriuretic peptide responses to a hypertonic saline infusion in conscious anephric rats.
    Ota K; Kimura T; Inoue M; Funyu T; Shoji M; Sato K; Ohta M; Yamamoto T; Abe K
    Eur J Endocrinol; 1995 Jul; 133(1):127-32. PubMed ID: 7627334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
    Graffe CC; Bech JN; Lauridsen TG; Pedersen EB
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F917-27. PubMed ID: 22262484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
    Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB
    Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.